Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (131-140 of 216) with videos related to

Pageof 22
Sort By:
Arthritis and Rheumatism|September 29, 2011
Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritisThomas Karonitsch, Karolina von Dalwigk, Carl W Steiner, et al.
Lupus|November 5, 2021
Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients - Analysis of the German LuLa studyAnna Kernder, Christina Düsing, Jutta Richter, et al.
International Journal of Molecular Sciences|February 18, 2017
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with AbirateroneMartin Boegemann, Katrin Schlack, Stefan Thomes, et al.
Lupus|March 13, 2023
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working groupWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Clinical and Experimental Rheumatology|December 7, 2021
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with ageChristof Specker, Martin Aringer, Gerd-Rüdiger Burmester, et al.
Arthritis and Rheumatism|October 2, 2007
Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health statusTanja A Stamm, Bettina Bauernfeind, Michaela Coenen, et al.
Diabetes Care|December 29, 2017
Immunoadsorption Followed by Rituximab as a Definitive Treatment for Insulin Autoimmune Syndrome (Hirata Syndrome): A Case ReportTim M Kroemer, Anne Erler, Elena Tsourdi, et al.
Arthritis Care & Research|May 26, 2017
Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic DataNicolai Leuchten, Annika Hoyer, Ralph Brinks, et al.
Clinical and Experimental Rheumatology|January 9, 2023
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational studyFrank Behrens, Gerd-Rudiger Burmester, Michael W Hofmann, et al.
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Pageof 22

Showing results (131-140 of 216) with videos related to

Sort By:
Pageof 22
Arthritis and Rheumatism|September 29, 2011
Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritisThomas Karonitsch, Karolina von Dalwigk, Carl W Steiner, et al.
Lupus|November 5, 2021
Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients - Analysis of the German LuLa studyAnna Kernder, Christina Düsing, Jutta Richter, et al.
International Journal of Molecular Sciences|February 18, 2017
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with AbirateroneMartin Boegemann, Katrin Schlack, Stefan Thomes, et al.
Lupus|March 13, 2023
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working groupWils Nielsen, Vibeke Strand, Lee S Simon, et al.
Clinical and Experimental Rheumatology|December 7, 2021
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with ageChristof Specker, Martin Aringer, Gerd-Rüdiger Burmester, et al.
Arthritis and Rheumatism|October 2, 2007
Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health statusTanja A Stamm, Bettina Bauernfeind, Michaela Coenen, et al.
Diabetes Care|December 29, 2017
Immunoadsorption Followed by Rituximab as a Definitive Treatment for Insulin Autoimmune Syndrome (Hirata Syndrome): A Case ReportTim M Kroemer, Anne Erler, Elena Tsourdi, et al.
Arthritis Care & Research|May 26, 2017
Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic DataNicolai Leuchten, Annika Hoyer, Ralph Brinks, et al.
Clinical and Experimental Rheumatology|January 9, 2023
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational studyFrank Behrens, Gerd-Rudiger Burmester, Michael W Hofmann, et al.
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Pageof 22